Bacterial meningitis is the most common serious infection of the central nervous system (CNS) and a major cause of death and disability worldwide, especially in children. Although antibiotic therapy has changed bacterial meningitis from a uniformly fatal disease to an often curable one, the overall outcome remains unfavorable, with mortality of 5 to 10% and permanent neurologic sequelae occurring in 5 to 40% of survivors, depending on patient age and pathogen. Disruption and dysfunction of the blood-brain barrier (BBB) is a hallmark event in the pathophysiology of bacterial meningitis. Little is known, however, about the very first and crucial interaction between a bacterial pathogen with the BBB that initiates this chain of events, and may ultimately determine a poor or favorable neurological outcome in meningitis patients. This proposal seeks to elucidate the molecular mechanisms of BBB response and function during bacterial infection, and why it fails as a neuroprotective barrier during bacterial meningitis. I hypothesize that BBB disruption may be due to the combined effect of bacterial entry and penetration of brain microvascular endothelium, direct cellular injury by bacterial cytotoxins, and/or activation of host inflammatory pathways that compromise barrier function. These hypotheses will be addressed with both in vitro and in vivo models of BBB penetration using Group B streptococcus as a model human pathogen associated with meningitis. Studies will also utilize isogenic bacterial mutants lacking important virulence factors such as regulators, """"""""invasins"""""""", and cytotoxins;various knockout and transgenic mice;and key molecular tools to modulate host response pathways in the following specific aims:
AIM 1 : Characterize the bacterial-host interactions leading to immune activation and bacterial BBB invasion;
AIM 2 : Elucidate the mechanisms of bacterial intracellular trafficking and BBB traversal;
AIM 3 : Determine the contribution of bacterial factors and host innate immune response pathways to BBB permeability and the pathogenesis of bacterial meningitis. These data will build upon and complement our observations to clarify the crucial position of the brain endothelium in innate immune defense against bacterial pathogens. The knowledge gained as a result of this proposal into the mechanisms of leukocyte and bacterial-brain penetration will provide fundamental and novel insights in the pathogenesis and treatment strategies of bacterial meningitis and other neurodegenerative disorders.

Public Health Relevance

Bacterial meningitis is the most common serious infection of the central nervous system (CNS) and a major cause of death and disability worldwide, especially in children. Disruption and dysfunction of the blood-brain barrier (BBB) is a hallmark event in the pathophysiology of bacterial meningitis. My research proposal seeks to characterize, at the molecular and cellular level, BBB response and function during bacterial infection, and why it fails as a neuroprotective barrier.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS051247-08
Application #
8318073
Study Section
Immunity and Host Defense Study Section (IHD)
Program Officer
Wong, May
Project Start
2005-04-01
Project End
2016-03-31
Budget Start
2012-04-01
Budget End
2013-03-31
Support Year
8
Fiscal Year
2012
Total Cost
$327,031
Indirect Cost
$108,281
Name
San Diego State University
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
073371346
City
San Diego
State
CA
Country
United States
Zip Code
92182
Deng, Liwen; Mu, Rong; Weston, Thomas A et al. (2018) Characterization of a two-component system transcriptional regulator LtdR that impacts Group B Streptococcal colonization and disease. Infect Immun :
Vornhagen, Jay; Armistead, Blair; Santana-Ufret, Verónica et al. (2018) Group B streptococcus exploits vaginal epithelial exfoliation for ascending infection. J Clin Invest 128:1985-1999
Gendrin, Claire; Shubin, Nicholas J; Boldenow, Erica et al. (2018) Mast cell chymase decreases the severity of group B Streptococcus infections. J Allergy Clin Immunol 142:120-129.e6
Lazzarin, Maddalena; Mu, Rong; Fabbrini, Monica et al. (2017) Contribution of pilus type 2b to invasive disease caused by a Streptococcus agalactiae ST-17 strain. BMC Microbiol 17:148
Kim, Brandon J; Bee, Olivia B; McDonagh, Maura A et al. (2017) Modeling Group B Streptococcus and Blood-Brain Barrier Interaction by Using Induced Pluripotent Stem Cell-Derived Brain Endothelial Cells. mSphere 2:
Hancock, Bryan M; Doran, Kelly S (2017) Importance of strain lineages for Group B streptococcal survival. Virulence 8:646-648
Mu, Rong; Cutting, Andrew S; Del Rosario, Yvette et al. (2016) Identification of CiaR Regulated Genes That Promote Group B Streptococcal Virulence and Interaction with Brain Endothelial Cells. PLoS One 11:e0153891
Patras, Kathryn A; Doran, Kelly S (2016) A Murine Model of Group B Streptococcus Vaginal Colonization. J Vis Exp :
Doran, Kelly S; Fulde, Marcus; Gratz, Nina et al. (2016) Host-pathogen interactions in bacterial meningitis. Acta Neuropathol 131:185-209
Patras, K A; Rösler, B; Thoman, M L et al. (2015) Characterization of host immunity during persistent vaginal colonization by Group B Streptococcus. Mucosal Immunol 8:1339-48

Showing the most recent 10 out of 46 publications